"Receptors, Interleukin-7" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors that are specific for INTERLEUKIN-7. They are present on T-LYMPHOCYTES and B-LYMPHOCYTE precursors. The receptors are heterodimeric proteins consisting of the INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT and the CYTOKINE RECEPTOR COMMON BETA SUBUNIT.
| Descriptor ID |
D020395
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.420
|
| Concept/Terms |
Receptors, Interleukin-7- Receptors, Interleukin-7
- Receptors, Interleukin 7
- Interleukin-7 Receptors
- Interleukin 7 Receptors
- IL7 Receptors
- Receptors, IL7
- IL-7 Receptor
- IL 7 Receptor
- Receptor, IL-7
- IL-7 Receptors
- IL 7 Receptors
- IL7 Receptor
- Interleukin 7 Receptor
- Receptor, Interleukin 7
- Receptors, IL-7
- Receptors, IL 7
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-7".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-7".
This graph shows the total number of publications written about "Receptors, Interleukin-7" by people in this website by year, and whether "Receptors, Interleukin-7" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2016 | 1 | 1 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Interleukin-7" by people in Profiles.
-
Interleukin-7 potentiates MAPK10-elicited host-protective vaccine against Leishmania donovani. Cytokine. 2024 02; 174:156475.
-
Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma. Cancer Biol Med. 2023 06 27; 20(8).
-
BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells. Leukemia. 2017 03; 31(3):678-687.
-
Interdependent IL-7 and IFN-? signalling in T-cell controls tumour eradication by combined a-CTLA-4+a-PD-1 therapy. Nat Commun. 2016 08 08; 7:12335.
-
TSLP or IL-7 provide an IL-7Ra signal that is critical for human B lymphopoiesis. Eur J Immunol. 2016 09; 46(9):2155-61.
-
LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors. J Clin Invest. 2016 Apr 01; 126(4):1267-81.
-
Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray. Clin Exp Immunol. 2014 Dec; 178(3):459-69.
-
Identification of novel genetic risk loci in Maltese dogs with necrotizing meningoencephalitis and evidence of a shared genetic risk across toy dog breeds. PLoS One. 2014; 9(11):e112755.
-
Reversal of tumor immune inhibition using a chimeric cytokine receptor. Mol Ther. 2014 Jun; 22(6):1211-1220.
-
Interleukin-7 mediates selective expansion of tumor-redirected cytotoxic T lymphocytes (CTLs) without enhancement of regulatory T-cell inhibition. Clin Cancer Res. 2014 Jan 01; 20(1):131-9.